Form 8-K - Current report:
SEC Accession No. 0001628280-19-014611
Filing Date
2019-11-29
Accepted
2019-11-29 17:23:23
Documents
3
Period of Report
2019-11-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K vibativpub11-25x191.htm 8-K 38727
2 EXHIBIT 99.1 vibativpub112519ex991.htm EX-99.1 28179
3 cumberlandlog.jpg GRAPHIC 28402
  Complete submission text file 0001628280-19-014611.txt   107176
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 191261665
SIC: 2834 Pharmaceutical Preparations